Litcius/Paper detail

Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging

Jamieson M. Bourque, Christopher A. Hanson, Denis Agostini, Timothy M. Bateman, Jeroen J. Bax, Rob Beanlands, Daniel S. Berman, Ernest Garcia, Gary V. Heller, Juhani Knuuti, Nagara Tamaki, James E. Udelson, Jamshid Maddahi

2021Journal of Nuclear Cardiology18 citationsDOI

Topics & Concepts

MedicineCoronary artery diseaseMyocardial perfusion imagingPositron emission tomographyClinical endpointNuclear medicineRadiologyCADPerfusionInternal medicineClinical trialEngineeringEngineering drawingCardiac Imaging and DiagnosticsCardiovascular Disease and AdiposityCerebrovascular and Carotid Artery Diseases
Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging | Litcius